1. Gaythorpe KA, Hamlet A, Jean K, Garkauskas Ramos D, Cibrelus L, Garske T,Ferguson N. Elife. The global burden ofyellowfever. 2021 Mar 16;10:e64670. doi: 10.7554/eLife.64670.PMID:33722340,
2. World Health Organization. Yellow fever vaccine, WHO position paper. Weekly Epidemiological Record, 2013, 88:269–284. https://www.who.int/wer/2013/wer8827.pdf?ua=1.
3. WHO Recommendations to assure the quality safety and efficacy of live attenuated yellow fever vaccines. In: WHO Expert Committee on Biological Standardization: sixty-first report. Geneva: World Health Organization; 2013: Annex 5 (WHO Technical Report Series, No. 978). https://cdn.who.int/media/docs/default-source/biologicals/vaccine-standardization/yellow-fever/trs_978_annex_5.pdf?sfvrsn=446b9c12_3&download=true .
4. Recommendations to assure the quality, safety and efficacy of poliomyelitis vaccines (oral, live, attenuated). In: WHO Expert Committee on Biological Standardization: sixty-third report. Geneva: World Health Organization; 2014: Annex 2 (WHO Technical Report Series, No. 980). https://cdn.who.int/media/docs/default-source/biologicals/vaccine-standardization/poliomyelitis/opv_recommendations_trs_980_annex_2.pdf?sfvrsn=c2c7b612_3&download=true .
5. Revision of the WHO Recommendations to assure the quality, safety and efficacy of live attenuated yellow fever vaccines. In: WHO Expert Committee on Biological Standardization: seventy-first report. Geneva: World Health Organization; 2021 (WHO Technical Report Series, No. 1028, section 3.2.3, pp.20–1;). https://www.who.int/publications/i/item/9789240020146 .